
Keywords: Chronic lung allograft dysfunction (CLAD), Bronchiolitis Obliterans Syndrome (BOS), Restrictive Allograft Syndrome (RAS), Lung allograft rejection, IL-17, Epithelial injury, Club cells, Club cell secretory protein, Biomarkers, Immune cells
Tereza Martinu, MD, MHSc
Clinician Scientist, Toronto Lung Transplant Program, UHN
CLAD team, in collaboration with the Juvet Laboratory
Scientist, Toronto General Hospital Research Institute
Associate Professor, University of Toronto: Temerty Faculty of Medicine, Institute of Medical Science, Immunology
Our group focuses on chronic lung allograft dysfunction (CLAD), the major cause of death beyond one year after lung transplantation. We apply single cell transcriptomics, proteomics, flow cytometry and microscopy imaging approaches to novel mouse models of CLAD, human lung-derived samples generously provided by our patients, as well as in-vitro cell culture systems. These strategies are used to study immune pathways, epithelial injury, and fibrosis in CLAD pathogenesis. Our goal is to elucidate mechanisms of CLAD and identify novel diagnostic and therapeutic targets for this condition.





